AVI Products (523896)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at book value with P/B of 1.00, so no premium is being paid to stated net assets.
• ROCE is positive at 1.97%, indicating some operating-level return remains despite net losses.
• Price is near the 52-week low of ₹20.11, suggesting limited downside if the stated book value is genuine.
• Tiny market cap means no growth premium is built into the stock price.

Concerns

• Sales collapsed by 70.8% and the latest quarter reported sales of ₹0 crore.
• Profit growth of -1,366.67% and ROE of -19.31% show losses are eroding shareholder equity.
• Piotroski F-score of 3/9 and zero dividend indicate poor financial health and no reward for waiting.
• Promoter holding is not disclosed, leaving governance and alignment unclear.

AI Analysis

Let’s start with the obvious: AVI Products is not a business I would want to own. It is a small trading and distribution operation with a market cap of just ₹7 crore and no evident competitive advantage. The figures are a parade of red flags. Sales have collapsed by 70.8%, and the latest quarter reported sales of ₹0 crore. Profit growth of -1,366.67% tells me the bottom line has swung into deep losses. Return on equity is -19.31%; every rupee of book value is being eroded, not compounded. Rock-bottom ROCE of 1.97% means the business barely generates any return on capital employed. The Piotroski F-score is 3 out of 9, which points to fundamental weakness. The stock at ₹20.40 trades almost exactly at book value of ₹20.44, and the P/B is 1.00. But Graham warned that a low P/B is not automatically cheap. If the assets cannot earn a satisfactory return, their book value is only an accounting figure, not economic value. A ₹7 crore market cap and zero dividend mean this is a microcap with no income for waiting. Promoter holding is not available, so I cannot judge alignment. With sales at zero in the latest quarter and no margin of safety, this looks more like a value trap than an asset play. I need evidence that the underlying business can resume sales, generate profits, and earn a return above cost of capital. Without that, the reasonable investor simply passes. In Buffett’s words, it’s better to buy a wonderful company at a fair price than a fair company at a wonderful price. This is neither wonderful nor fair.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer